Infection Control Today® Editorial Staff


Year Zero: How COVID-19 Changed Everything

December 23, 2020

Though tough months lie ahead for infection preventionists and other healthcare professionals, hope remains that at some point in 2021 things will begin to settle down. In the end, it comes down to a simple formula: We win, COVID-19 loses.

Update: Eli Lilly’s Anti-COVID Product Approved by FDA

November 11, 2020

Bamlanivimab, a monoclonal antibody, can be used for anyone 65 or older. It can also be used for patients 12 and over who have an underlying health condition and have been diagnosed with mild-to-moderate COVID-19.